Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Talis Biomedical Corp as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −4 vs. Q2 2021
- Shares held
- 19.1M
- −494.1K (−2.5%) vs. Q2 2021
- Total value
- $119.2M
- −$64.4M (−35.1%) vs. Q2 2021
- New holders
- 7
- 16 more added
- Sold out
- 11
- 8 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLIS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $26 |
| Q3 2024 | 2 | $460.4K |
| Q2 2024 | 18 | $6.84M |
| Q1 2024 | 18 | $6.93M |
| Q4 2023 | 18 | $5.93M |
| Q3 2023 | 19 | $4.27M |
| Q2 2023 | 22 | $5.27M |
| Q1 2023 | 22 | $5.76M |
| Q4 2022 | 27 | $5.60M |
| Q3 2022 | 29 | $8.59M |
| Q2 2022 | 35 | $12.1M |
| Q1 2022 | 45 | $23.6M |
| Q4 2021 | 47 | $70.2M |
| Q3 2021 | 38 | $119.2M |
| Q2 2021 | 43 | $184.0M |
| Q1 2021 | 45 | $269.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Talis Biomedical Corp; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Group One Trading, L.P. | 825 | $5.00K | 0.00% | +825 | New |
| Legal & General Group Plc | 1,074 | $7.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,077 | $7.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,793 | $11.0K | 0.00% | +1,108+161.8% | Added |
| Royal Bank of Canada | 1,887 | $12.0K | 0.00% | +716+61.1% | Added |
| Advisor Group Holdings, Inc. | 2,150 | $13.0K | 0.00% | +1,000+87.0% | Added |
| California State Teachers Retirement System | 7,775 | $49.0K | 0.00% | −12,150−61.0% | Reduced |
| American International Group, Inc. | 7,907 | $49.0K | 0.00% | −188−2.3% | Reduced |
| Chicago Partners Investment Group LLC | 10,000 | $54.0K | 0.00% | +10,000 | New |
| ETF Managers Group, LLC | 9,295 | $56.0K | 0.00% | +1,734+22.9% | Added |
| Janney Montgomery Scott LLC | 10,000 | $62.0K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 12,337 | $77.0K | 0.00% | +12,337 | New |
| Rhumbline Advisers | 12,581 | $79.0K | 0.00% | −395−3.0% | Reduced |
| Tower Research Capital LLC (TRC) | 13,464 | $85.0K | 0.00% | +12,292+1,048.8% | Added |
| Deutsche Bank AG | 15,007 | $94.0K | 0.00% | +6,935+85.9% | Added |
| M&T Bank Corp | 15,202 | $95.0K | 0.00% | 00.0% | Unchanged |
| Personal Cfo Solutions, LLC | 17,000 | $106.0K | 0.02% | +17,000 | New |
| Mercer Global Advisors Inc | 20,035 | $125.0K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 23,298 | $146.0K | 0.00% | +23,298 | New |
| Citadel Advisors LLC | 26,146 | $163.0K | 0.00% | +26,146 | New |
| PDT Partners, LLC | 30,109 | $188.0K | 0.01% | +30,109 | New |
| Charles Schwab Investment Management Inc | 36,714 | $230.0K | 0.00% | −59,282−61.8% | Reduced |
| New York State Common Retirement Fund | 37,115 | $232.0K | 0.00% | −1,299−3.4% | Reduced |
| Nuveen Asset Management, LLC | 54,484 | $392.0K | 0.00% | +14,424+36.0% | Added |
| Bank of America Corp | 65,394 | $409.0K | 0.00% | +44,599+214.5% | Added |
| Parametric Portfolio Associates LLC | 77,972 | $487.0K | 0.00% | +27,476+54.4% | Added |
| JPMorgan Chase & Co | 83,068 | $520.0K | 0.00% | +40,838+96.7% | Added |
| Bank of New York Mellon Corp | 87,846 | $550.0K | 0.00% | +2,863+3.4% | Added |
| Northern Trust Corp | 130,617 | $817.0K | 0.00% | −8,195−5.9% | Reduced |
| State Street Corp | 238,587 | $1.49M | 0.00% | +32,662+15.9% | Added |
| Geode Capital Management, LLC | 302,968 | $1.89M | 0.00% | +44,925+17.4% | Added |
| Morgan Stanley | 314,614 | $1.97M | 0.00% | −127,636−28.9% | Reduced |
| Vanguard Group Inc | 568,757 | $3.56M | 0.00% | +23,851+4.4% | Added |
| BlackRock Inc. | 813,137 | $5.08M | 0.00% | +5,838+0.7% | Added |
| Nicholas Investment Partners, LP | 989,090 | $6.18M | 0.45% | −82,225−7.7% | Reduced |
| Boxer Capital, LLC | 1,550,998 | $9.69M | 0.34% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 5,893,876 | $36.8M | 0.29% | +21,951+0.4% | Added |
| Baker Bros. Advisors LP | 7,574,835 | $47.3M | 0.21% | 00.0% | Unchanged |
| Redmile Group, LLC | 0 | $0 | 0.00% | −363,849−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −29,636−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −22,920−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −19,557−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −18,585−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −14,219−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −11,326−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −541−100.0% | Sold out |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |